Last reviewed · How we verify
Vitamin E deficiency — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| M.V.I. Pediatric | VITAMIN E | Pfizer | Vitamin E | Glutathione S-transferase P | 1953-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Vitamin E deficiency
- Pfizer · 1 drug in Vitamin E deficiency
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Vitamin E deficiency:
- Vitamin E deficiency treatment updates — RSS
- Vitamin E deficiency treatment updates — Atom
- Vitamin E deficiency treatment updates — JSON
Cite this brief
Drug Landscape (2026). Vitamin E deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/vitamin-e-deficiency. Accessed 2026-06-10.
Related
- Vitamin E deficiency full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing